Skip to main content

Table 2 Positive cultures of MDROs from samples taken from contact surfaces during the 1-year study

From: Allocation of the ICU wards according to the patient’s infection condition: a measure to improve antibiotic resistance

Time

MDROs [n (%)]

P value

ICU-1 [n/N (n%), N = 100]

ICU-2 [n/N (n%), N = 60]

Baseline

30/300 (10.0%)

12/180 (6.7%)

0.109

 2018, Mar

9/100 (9.0%)

7/60 (11.7%)

 2018, Apr

11/100 (11.0%)

4/60 (6.7%)

 2018, May

10/100 (10.0%)

1/60 (1.7%)

Intervention

31/900 (3.4%)

0/540 (0.0%)

0.007

 2018, Jun

4/100 (4.0%)

0/60 (0.0%)

 2018, Jul

7/100 (7.0%)

0/60 (0.0%)

 2018, Aug

1/100 (1.0%)

0/60 (0.0%)

 2018, Sep

2/100 (2.0%)

0/60 (0.0%)

 2018, Oct

4/100 (4.0%)

0/60 (0.0%)

 2018, Nov

2/100 (2.0%)

0/60 (0.0%)

 2018, Dec

1/100 (1.0%)

0/60 (0.0%)

 2019, Jan

3/100 (3.0%)

0/60 (0.0%)

 2019, Feb

7/100 (7.0%)

0/60 (0.0%)

Pvalue

<0.001

<0.001

 
  1. ICU intensive care unit, MDROs multidrug-resistant organisms